Clinical Trials Logo

Filter by:
NCT ID: NCT05154136 Completed - Clinical trials for Healthy Participants

A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants

Start date: October 20, 2021
Phase: Phase 1
Study type: Interventional

This study will evaluate the effect of multiple oral doses of itraconazole, on the pharmacokinetics of etrumadenant when etrumadenant is administered as a single dose in healthy adult participants.

NCT ID: NCT05154045 Completed - Glycemic Control Clinical Trials

Postprandial Glycemic Response in Adults With Type 2 Diabetes

Start date: April 9, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, crossover study to compare the effects of two treatments on postprandial glucose in adults with type 2 diabetes.

NCT ID: NCT05153863 Completed - Shoulder Injuries Clinical Trials

C Scope Visualization System Prospective Study

Start date: January 20, 2022
Phase: N/A
Study type: Interventional

Evaluation of the performance and safety of the C Scope Visualization System

NCT ID: NCT05153629 Completed - Kidney Stone Clinical Trials

Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy

Start date: January 10, 2021
Phase: N/A
Study type: Interventional

The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.

NCT ID: NCT05153577 Completed - Food Insecurity Clinical Trials

Fresh Start: Increasing Early Produce Intake

Start date: June 9, 2021
Phase: N/A
Study type: Interventional

Nearly 22% of children in Philadelphia live in food-insecure (FI) households, often leading to reliance on inexpensive, nutrient-poor foods and associated poor health outcomes. Despite this, utilization of food benefit programs is often low, including the Special Supplemental Nutrition Program Women, Infants, and Children (WIC) Farmer's Market Nutrition Program (FMNP). In the prior qualitative study, Investigators found that parents desire to increase their children's intake of produce but face many barriers to produce access; caregivers described a preference for delivery-based, low-or-no cost food programs to increase produce access and intake among children. This pilot trial seeks to assess the effectiveness of a short-term, tiered-fee produce delivery program in retaining participants and increasing produce access and intake among families with WIC-eligible children

NCT ID: NCT05153551 Completed - Clinical trials for Autism Spectrum Disorder

Pediatric Early Autism Recognition System: PEARS

PEARS
Start date: January 27, 2022
Phase: N/A
Study type: Interventional

The goal of the study is to assess a new autism evaluation model that would include the addition of a Level-2 autism screener, the Rapid Interactive Screening Test for Autism in Toddlers (RITA-T), to the developmental screening already done by the child's pediatrician. The study hypotheses: 1. The PEARS intervention will show high feasibility to primary care physicians (PCPs) and patient families. 2. The PEARS intervention will lead to increased parent activation around autism diagnosis.

NCT ID: NCT05153278 Completed - Clinical trials for Iron Deficiency Anemia

IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department

Start date: October 26, 2018
Phase:
Study type: Observational

The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient records reviewed will be from patients who were infused at UMC ED from January 2013 to June 2018. Primary aim of analysis will be to investigate superiority between interventions implemented for treating IDA. In addition, the investigators will utilize data to characterize patients who used ED services as an avenue to receive treatment for IDA. Further, the investigators will conduct cost analysis between different IDA directed treatments administered in the ED at UMC.

NCT ID: NCT05153265 Completed - Anesthesia, Local Clinical Trials

The CIA Score: a Learner's Tool

Start date: November 23, 2021
Phase:
Study type: Observational

The goal of this project is to use a previously described scoring system - the CIA system - as a teaching tool to help learners assess the bleeding risk of peripheral nerve blocks. We will teach the CIA system to residents, then they will complete a survey in which they apply the system to various peripheral nerve blocks. We hypothesize that the CIA system will allow learners to reach the same consensus about bleeding risk as expert opinions.

NCT ID: NCT05153174 Completed - Clinical trials for Chronic Kidney Disease stage4

Study of Sulphoraphane in Chronic Kidney Disease

Start date: May 2, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to test the safety of the compound sulforaphane that boosts the activity of antioxidant genes in the body to combat oxidative stress. Oxidative stress has been shown experimentally to play a role in kidney disease. This drug has been tested in patients with breast cancer who have normal kidney function, but has never been tested in patients with kidney disease. In this study, the investigators will establish a safe dose for patients with chronic kidney disease based on blood levels achieved in patients with normal kidney function.

NCT ID: NCT05153161 Completed - Alzheimer Disease Clinical Trials

Memesto Wearable Device for Persons With Dementia

Start date: August 31, 2022
Phase: Phase 1
Study type: Interventional

An estimated 70% of the 7.2+ million people in the U.S. with Alzheimer's Disease and Alzheimer's Disease-Related Dementias experience agitation, characterized by poorly organized and purposeless psychomotor activity that diminishes their quality of life. The goal of this Small Business Innovation Research (SBIR) project is to develop a wearable therapy device that automatically senses rising agitation, and alerts caregivers while deploying calming voice and music therapy to help them avoid crisis level behavior. This device will improve health outcomes for AD/ADRD sufferers and reduce the substantial stress suffered by their caregivers.